As BridgeBio approaches its FDA target date for approval of TTR stabilizer acoramidis to treat the rare heart disease transthyretin amyloid cardiomyopathy (ATTR-CM), the company has presented more ...
While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...
Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...
The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s tissue-specific delivery vehicle to transport gene editing cargo to the lung cells ...
In a discussion with the Cobb Institute, Dr. Priscilla Pemu and Tesheia Harris shared insights on how to make clinical trials more inclusive.
Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...
The NHS DigiTrials initiative is supporting three major cancer projects, which will aim to recruit tens of thousands of ...
Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...
The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...
The NHS is launching a search for nearly 150,000 volunteers to take part in a series of research trials that could transform cancer treatment. Three cancer projects have been selected as part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback